{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:07:38Z","timestamp":1789956458666,"version":"4.0.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pfizer Investigator-Initiated Research","award":["WS2240898"],"award-info":[{"award-number":["WS2240898"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154092","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T13:36:35Z","timestamp":1461332195000},"page":"e0154092","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":81,"title":["Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries"],"prefix":"10.1371","volume":"11","author":[{"given":"Maria Virginia","family":"Villegas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J.","family":"Pallares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7173-7486","authenticated-orcid":true,"given":"Kevin","family":"Escand\u00f3n-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristhian","family":"Hern\u00e1ndez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Matta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannete","family":"Zurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Mej\u00eda-Villatoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Rodr\u00edguez-Noriega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Seas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Cortes\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Guzm\u00e1n-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Guzm\u00e1n-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"LS Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1086\/592412","article-title":"Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies","volume":"29","author":"G Patel","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.2015.12480","article-title":"Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012\u20132013","volume":"314","author":"AY Guh","year":"2015","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.medmal.2013.11.007","article-title":"Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge","volume":"44","author":"P Nordmann","year":"2014","journal-title":"Med Mal Infect. Elsevier Masson SAS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/14787210.2013.811924","article-title":"Current status of carbapenemases in Latin America","volume":"11","author":"JJ Maya","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/AAC.01020-07","article-title":"Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality","volume":"52","author":"MJ Schwaber","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1469-0691.2009.03115.x","article-title":"Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control","volume":"16","author":"Y Carmeli","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3201\/eid2007.121004","article-title":"Deaths attributable to carbapenem-resistant Enterobacteriaceae infections","volume":"20","author":"ME Falagas","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"O117","DOI":"10.1111\/1469-0691.12341","article-title":"Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options","volume":"20","author":"F Kontopidou","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1586\/eri.12.138","article-title":"Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective","volume":"10","author":"GL Daikos","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jhin.2012.10.012","article-title":"Impact of carbapenem resistance on the outcome of patients\u2019 hospital-acquired bacteraemia caused by Klebsiella pneumoniae","volume":"83","author":"K Hussein","year":"2013","journal-title":"J Hosp Infect"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1469-0691.2011.03478.x","article-title":"Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections","volume":"18","author":"D Ben-David","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1086\/605922","article-title":"Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia","volume":"30","author":"A Borer","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.diagmicrobio.2010.10.013","article-title":"Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections","volume":"69","author":"EA Neuner","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: Importance of combination therapy","volume":"55","author":"M Tumbarello","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/j.1469-0691.2011.03514.x","article-title":"Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment","volume":"17","author":"O Zarkotou","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1128\/AAC.02166-13","article-title":"Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems","volume":"58","author":"GL Daikos","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cmi.2014.07.010","article-title":"Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins","volume":"21","author":"MS de Oliveira","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/AAC.00782-08","article-title":"Prospective observational study of the impact of VIM-1 metallo-\u03b2-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections","volume":"53","author":"GL Daikos","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1111\/1469-0691.12091","article-title":"Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge","volume":"19","author":"C Navarro-San Francisco","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1086\/657135","article-title":"Bloodstream infections caused by metallo-\u03b2-lactamase\/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes","volume":"31","author":"E Mouloudi","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bjid.2013.07.002","article-title":"Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)","volume":"17","author":"RN Jones","year":"2013","journal-title":"Brazilian J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7705\/biomedica.v34i0.1667","article-title":"Evolution of antimicrobial resistance in Gram negative bacilli from intensive care units in Colombia","volume":"34","author":"C Hern\u00e1ndez-G\u00f3mez","year":"2014","journal-title":"Biom\u00e9dica"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"MM Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/648451","article-title":"Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"30","author":"LB Gasink","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7705\/biomedica.v34i0.1642","article-title":"Prevalence of gram-negative bacteria harboring blaKPC gene in Colombian hospitals","volume":"34","author":"R Pacheco","year":"2014","journal-title":"Biomedica"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary","volume":"11","author":"JW Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"ref28","article-title":"Performance standards for antimicrobial susceptibility testing. CLSI M100\u2013S24","year":"2014"},{"key":"ref29","unstructured":"CDC \/ NHSN. Surveillance Definitions for Specific Types of Infections. 2014."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1128\/JCM.02117-12","article-title":"Laboratory detection of Enterobacteriaceae that produce carbapenemases","volume":"50","author":"D Doyle","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1128\/AAC.01666-12","article-title":"Emergence of Klebsiella pneumoniae coharboring KPC and VIM carbapenemases in Colombia","volume":"57","author":"LJ Rojas","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jac\/28.4.499","article-title":"Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes","volume":"28","author":"JW Chow","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(05)62567-6","article-title":"Emergence of a carbapenem- resistant Klebsiella pneumoniae","volume":"350","author":"FM MacKenzie","year":"1997","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3201\/eid1208.060291","article-title":"Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing","volume":"12","author":"FC Tenover","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/joim.12342","article-title":"Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control","volume":"277","author":"T T\u00e4ngd\u00e9n","year":"2015","journal-title":"J Intern Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jac\/dkm356","article-title":"Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study","volume":"60","author":"ME Falagas","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1086\/661279","article-title":"Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel","volume":"32","author":"D Ben-David","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1128\/AAC.06268-11","article-title":"Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: Superiority of combination antimicrobial regimens","volume":"56","author":"ZA Qureshi","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T01:27:19Z","timestamp":1540344439000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154092"}},"subtitle":[],"editor":[{"given":"Linda Anne","family":"Selvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,22]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154092","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,22]]}}}